Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diatos S.A.
Paris, Francediatos.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Diatos S.A. was a Paris-based biopharmaceutical company focused on developing improved chemotherapeutic agents with enhanced tumor targeting or biodistribution using proprietary prodrug and drug delivery platforms such as Vectocell®. Its lead product, DaunoXome®, was marketed for Kaposi's sarcoma and under review for AML; additional candidates included DTS‑201 and DTS‑108 targeting solid tumors. The company advanced at least eight compounds through clinical development before its core technology assets were acquired by others.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesProdrugsLiposomal formulations (e.g., DaunoXome®)
- Industry
- Biotech
02
Partnerships
Drais Pharmaceuticals – global agreement to develop/commercialize DTS–108 ($46.9M non–royalty value)Gilead Sciences – exclusive licensing agreement for DaunoXome worldwide rightsMedarex – European commercialization rights granted to Diatos for DTS–201.
Beyond the preview
Go deeper on Diatos S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diatos S.A..